Switching Therapies in Advanced Renal Cell Carcinoma

Following progression on first-line therapy, patients with renal cell carcinoma (RCC) often do not need to be hurried to second-line treatment, says David F. McDermott, MD. If there is existing disease that is not harming the patient, and the patient feels well, there is no reason to switch therapies, adds Eric Jonasch, MD.09/22/2015
Source: Kidney Cancer Association - Category: Cancer & Oncology Source Type: news